Bulletin of RSMU

ORIGINAL RESEARCH

Experimental study of dendrimer-based nanoparticles with RGD-peptide for anticancer radionuclide therapy

Stukalov YuV¹, Grigorieva EYu¹, Smirnova AV^1,3, Lipengolts AA^1,2, Kubasova IYu¹, Pozdniakova NV¹, Lukashina MI⁴

About authors

¹ Blokhin National Medical Research Center of Oncology, Moscow

² Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Moscow, Russia

³ The Loginov Moscow Clinical Scientific Center, Moscow, Russia

⁴ Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow

Correspondеnce should be adressed: Elena Yu. Grigorieva
Kashirskoe shosse, 24, Moscow, 115478; ur.liam@11nele-girg

About paper

Received: 2018-09-12 Accepted: 2018-10-11 Published online: 2018-12-31

No data available...

Link to the next paper will be sent to the indicated e-mail's:

ORIGINAL RESEARCH Experimental study of dendrimer-based nanoparticles with RGD-peptide for anticancer radionuclide therapy

Stukalov YuV, Grigorieva EYu, Smirnova AV, Lipengolts AA, Kubasova IYu, Pozdniakova NV, Lukashina MI

Published in "Bulletin of RSMU" 6, 2018

I want to receive a copy of this message

Vancouver style

Stukalov YV, Grigorieva EY, Smirnova AV, Lipengolts AA, Kubasova IY, Pozdniakova NV, et al. Experimental study of dendrimer-based nanoparticles with RGD-peptide for anticancer radionuclide therapy . Bulletin of RSMU. 2018; (6): 113–9. DOI: 10.24075/brsmu.2018.089

Harvard style

Stukalov, Y. V., Grigorieva, E. Y., Smirnova, A. V., Lipengolts, A. A., Kubasova, I. Y., Pozdniakova, N. V., et al. (2018), "Experimental study of dendrimer-based nanoparticles with RGD-peptide for anticancer radionuclide therapy ", Bulletin of RSMU, no. 6, p. 113–119. DOI: 10.24075/brsmu.2018.089

Remember me

Forgot password?

I accept Editorial Policies of the journal

Archive

2018 / 06

ORIGINAL RESEARCH

Experimental study of dendrimer-based nanoparticles with RGD-peptide for anticancer radionuclide therapy